financetom
Business
financetom
/
Business
/
Oracle's Business Software Breached by Hackers at American Airlines Subsidiary Envoy Air
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Oracle's Business Software Breached by Hackers at American Airlines Subsidiary Envoy Air
Oct 17, 2025 11:10 AM

01:58 PM EDT, 10/17/2025 (MT Newswires) -- Oracle's (ORCL) E-Business Suite application was breached at American Airlines ( AAL ) subsidiary Envoy Air.

An Envoy spokesperson said in an email to MT Newswires that one of its IT systems was affected by the breach and that law enforcement had been contracted.

"We have conducted a thorough review of the data at issue and have confirmed no sensitive or customer data was affected," the spokesperson said Friday. "A limited amount of business information and commercial contact details may have been compromised."

The hack was part of a broader extortion campaign attributed to the Russian cybercriminal group Clop, according to multiple media reports.

Last week, Oracle said it released the latest patch addressing vulnerabilities in its E-Business Suite software.

Oracle shares fell 6.9% in Friday trading, and American Airlines ( AAL ) eased 0.2%.

Price: 291.37, Change: -21.63, Percent Change: -6.91

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ligand Pharmaceuticals' Partner Gets US FDA Approval for Ohtuvayre to Treat Chronic Obstructive Pulmonary Disease
Ligand Pharmaceuticals' Partner Gets US FDA Approval for Ohtuvayre to Treat Chronic Obstructive Pulmonary Disease
Jun 27, 2024
09:18 AM EDT, 06/27/2024 (MT Newswires) -- Ligand Pharmaceuticals ( LGND ) said Thursday its Verona Pharma partner has received approval for Ohtuvayre from the US Food and Drug Administration to treat chronic obstructive pulmonary disease in adult patients in more than 20 years. The company has earned a milestone payment of $5.8 million upon the regulator's approval of Ohtuvayre,...
Coherus BioSciences to Sell Yusimry to Hong Kong King-Friend Industrial in $40 Million Cash Transaction
Coherus BioSciences to Sell Yusimry to Hong Kong King-Friend Industrial in $40 Million Cash Transaction
Jun 27, 2024
09:21 AM EDT, 06/27/2024 (MT Newswires) -- Coherus BioSciences ( CHRS ) said Thursday it had agreed to sell its proprietary drug Yusimry to Hong Kong King-Friend Industrial for $40 million cash upfront. HKF's subsidiary Meitheal Pharmaceuticals will continue to commercialize Yusimry, a treatment for various types of arthritis, in the US, Coherus said. Coherus said the move was part...
Walgreens Cuts Full-Year Earnings Outlook on 'Challenging' Pharmacy, Consumer Trends
Walgreens Cuts Full-Year Earnings Outlook on 'Challenging' Pharmacy, Consumer Trends
Jun 27, 2024
09:19 AM EDT, 06/27/2024 (MT Newswires) -- Walgreens Boots Alliance ( WBA ) slashed its full-year earnings outlook on Thursday amid challenging pharmacy industry trends and a worsening retail environment, as the drug-store operator plans to close some underperforming US stores after quarterly profit missed market estimates. The company now anticipates adjusted earnings to be in a range of $2.80...
Why Recursion Pharmaceuticals Stock Is Tumbling Thursday
Why Recursion Pharmaceuticals Stock Is Tumbling Thursday
Jun 27, 2024
Recursion Pharmaceuticals Inc ( RXRX ) shares are trading lower Thursday after the company announced a proposed offering of its common stock. What Happened: Recursion announced that it intends to offer and sell 30,769,230 shares of its common stock for $6.50 per share in an underwritten public offering.  The clinical-stage biotech company also said it plans to grant the underwriters a 30-day option to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved